Insights

Innovative Fertility Solutions Ivy Natal offers groundbreaking biotechnology aimed at enabling women and same-sex couples to have genetic children, positioning the company at the forefront of reproductive innovation with a unique DNA activation approach.

Growing Market Potential With increasing awareness and acceptance of diverse family structures and fertility challenges, Ivy Natal's focus on advanced reproductive technologies creates substantial opportunities for partnerships, clinical trials, and distribution channels in the fertility and biotech sectors.

Strategic Tech Infrastructure Utilization of reliable cloud services like AWS and content delivery networks indicates scalable digital operations, facilitating outreach, data management, and potentially, remote patient engagement solutions in the future.

Funding and Growth Having secured $1.5 million in funding despite minimal current revenue suggests strong investor confidence in the company's innovative approach, providing a foundation for further R&D, clinical validation, and commercialization efforts.

Alignment with Key Partners Targeting partnerships or collaborations with established reproductive health companies and fertility clinics could enhance market penetration and credibility, leveraging Ivy Natal’s patent-pending technology to expand the reproductive options available to a broader patient base.

Ivy Natal Tech Stack

Ivy Natal uses 8 technology products and services including Amazon Web Services, Amazon CloudFront, Amazon S3, and more. Explore Ivy Natal's tech stack below.

  • Amazon Web Services
    Cloud Hosting
  • Amazon CloudFront
    Content Delivery Network
  • Amazon S3
    Content Delivery Network
  • cdnjs
    Content Delivery Network
  • Squarespace
    Content Management System
  • Open Graph
    Content Management System
  • Google Fonts API
    Font Scripts
  • Choices
    Javascript Libraries

Media & News

Ivy Natal's Email Address Formats

Ivy Natal uses at least 1 format(s):
Ivy Natal Email FormatsExamplePercentage
First@ivynatal.comJohn@ivynatal.com
50%
First@ivynatal.comJohn@ivynatal.com
50%

Frequently Asked Questions

Where is Ivy Natal's headquarters located?

Minus sign iconPlus sign icon
Ivy Natal's main headquarters is located at 479 Jessie Street San Francisco, California 94103 United States. The company has employees across 1 continents, including North America.

What is Ivy Natal's official website and social media links?

Minus sign iconPlus sign icon
Ivy Natal's official website is ivynatal.com and has social profiles on LinkedInCrunchbase.

What is Ivy Natal's SIC code NAICS code?

Minus sign iconPlus sign icon
Ivy Natal's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Ivy Natal have currently?

Minus sign iconPlus sign icon
As of February 2026, Ivy Natal has approximately 2 employees across 1 continents, including North America. Key team members include Director: M. N.. Explore Ivy Natal's employee directory with LeadIQ.

What industry does Ivy Natal belong to?

Minus sign iconPlus sign icon
Ivy Natal operates in the Biotechnology Research industry.

What technology does Ivy Natal use?

Minus sign iconPlus sign icon
Ivy Natal's tech stack includes Amazon Web ServicesAmazon CloudFrontAmazon S3cdnjsSquarespaceOpen GraphGoogle Fonts APIChoices.

What is Ivy Natal's email format?

Minus sign iconPlus sign icon
Ivy Natal's email format typically follows the pattern of First@ivynatal.com. Find more Ivy Natal email formats with LeadIQ.

How much funding has Ivy Natal raised to date?

Minus sign iconPlus sign icon
As of February 2026, Ivy Natal has raised $1.5M in funding. The last funding round occurred on Jan 01, 2022 for $1.5M.

When was Ivy Natal founded?

Minus sign iconPlus sign icon
Ivy Natal was founded in 2020.

Ivy Natal

Biotechnology ResearchCalifornia, United States2-10 Employees

Many women cannot have children except through the use of donor eggs. This can be due to surgery, chemotherapy, age, or genetic conditions. We aim to allow these patients to have genetic children for the first time, using a process which starts with a simple skin biopsy.

Our approach directly activates the skin cell’s existing DNA to transform it into a new, healthy egg cell. This avoids the challenges with traditional approaches to producing eggs and sperm in vitro.

Our goal is to give women confidence in their ability  to choose whether and when to have a child—and in the long term, ensure that every person and couple has the choice to have genetic children, including same-sex couples.

Section iconCompany Overview

Headquarters
479 Jessie Street San Francisco, California 94103 United States
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
2-10

Section iconMedia & News

Section iconFunding & Financials

  • $1.5M

    Ivy Natal has raised a total of $1.5M of funding over 2 rounds. Their latest funding round was raised on Jan 01, 2022 in the amount of $1.5M.

  • $1M

    Ivy Natal's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1.5M

    Ivy Natal has raised a total of $1.5M of funding over 2 rounds. Their latest funding round was raised on Jan 01, 2022 in the amount of $1.5M.

  • $1M

    Ivy Natal's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.